Cargando…

261 Comparative in vitro Activity of Sitafloxacin and Other Antibiotics Against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii and Carbapenem-Resistant Pseudomonas aeruginosa by Disk Diffusion Method

Detalles Bibliográficos
Autores principales:	Linasmita, Patcharasarn, Siengluecha, Nuntana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782249/ http://dx.doi.org/10.1093/ofid/ofu052.127

Ejemplares similares

337 Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii (CRAb) among ICU Patients Detected by CRAb-LAMP
por: Yamamoto, Norihisa, et al.
Publicado: (2014)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study
por: Vivo, Amanda, et al.
Publicado: (2022)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant Acinetobacter baumannii Infections: A Preliminary Study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022)

364 Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization
por: Lewis, Jessica, et al.
Publicado: (2014)

Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007–2009)
por: Kateete, David P., et al.
Publicado: (2016)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

338 Prevalence, Mortality and Outcomes of Antibiotic Therapy of Multi-Drug Resistant Acinetobacter baumannii
por: Lapensee, Kenneth T., et al.
Publicado: (2014)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

1675 A Novel Murine Pneumonia and Bacteremia Model for Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Kavanaugh, Michael, et al.
Publicado: (2014)

349 Surveillance of Carbapenem Resistance and the First Case of NDM-7-producing Klebsiella pneumoniae in the Philippines
por: Chou, Andrew, et al.
Publicado: (2014)

Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
por: Skalweit, Marion J, et al.
Publicado: (2016)

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cai, Bin, et al.
Publicado: (2017)

Trends in Carbapenem Susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates From Long-Term Acute Care Hospitals Across the United States-An Analysis of Antibiograms
por: Sudan, Sukhesh, et al.
Publicado: (2015)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

1805 Use of Stool Transplant to Clear Fecal Colonization with Carbapenem-Resistant Enterobacteraciae (CRE): Proof of Concept
por: Freedman, Abigail, et al.
Publicado: (2014)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran
por: Azimi, Leila, et al.
Publicado: (2020)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand
por: Paiboonvong, Taniya, et al.
Publicado: (2022)

1671 A Fatal Outbreak of a Rare but Emerging Clone of Extensively Drug-resistant Acinetobacter baumannii with Enhanced Virulence
por: Jones, Crystal, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

836 Central Nervous System Infections Caused by Acinetobacter baumannii.
por: Kyrillos, Ramona, et al.
Publicado: (2014)

415 In Vitro Potency of Ceftolozane/Tazobactam against Pseudomonas aeruginosa Displaying Multidrug Resistance
por: Sutherland, Christina, et al.
Publicado: (2014)

348 Rising incidence of carbapenem resistance in health care associated blood stream infections in a tertiary care hospital in Mumbai, India
por: Shah, Sweta, et al.
Publicado: (2014)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods
por: Rodjun, Vipavee, et al.
Publicado: (2020)

Distribution of carbapenem resistant Acinetobacter Baumannii and Pseudomonas aeruginosa and ESBL-producing organisms colonization among intensive care patients
por: Santanirand, P, et al.
Publicado: (2011)

Carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: characterization of carbapenemase genes and E-test evaluation of colistin-based combinations
por: Ramadan, Raghdaa A, et al.
Publicado: (2018)

Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis
por: Arowolo, Margaret Toluwalayo, et al.
Publicado: (2023)

Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study
por: Terahara, Fumitaka, et al.
Publicado: (2019)

Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene
por: Huang, Hua-Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0f4qr95eg6fc1qpk5k2iolfvk6